T1	Pharmacological_substance 43 57	phenylbutazone
N1000 	Reference T1 MeSH:D010653	phenylbutazone
T2	Disorder 66 95	serum sickness-like reactions
T3	Disorder 98 112	Serum sickness
N1 	Reference T3 UMLS:C0036830	Serum sickness
T5	Pharmacological_substance 383 397	phenylbutazone
N1001 	Reference T5 MeSH:D010653	phenylbutazone
T6	Pharmacological_substance 399 409	ranitidine
N1002 	Reference T6 MeSH:D011899	ranitidine
T7	Pharmacological_substance 411 423	clomipramine
N1003 	Reference T7 MeSH:D002997	clomipramine
T8	Pharmacological_substance 428 443	levomepromazine
N1004 	Reference T8 MeSH:D008728	levomepromazine
T9	Disorder 505 510	fever
N2 	Reference T9 UMLS:C0015967	fever
T10	Disorder 512 520	diarrhea
N3 	Reference T10 UMLS:C0011991	diarrhea
T11	Pharmacological_substance 667 677	metamizole
N1005 	Reference T11 MeSH:D004177	metamizole
T12	Pharmacological_substance 774 788	phenylbutazone
N1006 	Reference T12 MeSH:D010653	phenylbutazone
T16	Disorder 349 361	sacroileitis
N4 	Reference T16 UMLS:C0574960	sacroileitis
T4	Disorder 319 326	anxiety
N5 	Reference T4 UMLS:C0003469	anxiety
T17	Disorder 328 338	depression
N6 	Reference T17 UMLS:C0011570	depression
N7 	Reference T17 UMLS:C0011581	depression
T18	Subject 284 303	a 38-year-old woman
T15	Disorder 522 538	localized edemas
N8 	Reference T15 UMLS:C0013609	localized edemas
T19	Disorder 552 568	pruritic papular
N9 	Reference T19 UMLS:C0033772	pruritic papular
T20	Disorder 573 590	erythematous rash
T21	Disorder 595 612	lymphadenopathies
N10 	Reference T21 UMLS:C0497156	lymphadenopathies
T14	Disorder 10 29	Skin manifestations
T25	Coreferring_mention 463 472	treatment
T27	Coreferring_mention 486 489	she
T28	Coreferring_mention 614 617	She
T29	Coreferring_mention 632 645	same symptoms
T31	Pharmacological_substance 241 258	foreign substance
